Supply of 96-Well BLACK MEA Plates

The contract pertains to the supply of newly manufactured Cytoview 96-well BLACK MEA plates, specifically model M768-tMEA-96B, designed for compatibility with Axion Biosystems platforms to enable real-time electrophysiological recordings using human induced pluripotent stem cell derived cardiomyocytes. These plates are essential for high-throughput, cell-based cardiac assays and must meet strict manufacturing standards to ensure consistent performance in sensitive electrophysiological applications. The requirement is issued as a subcontract under a Total Small Business Set-Aside designation, meaning only small businesses certified by the Small Business Administration are eligible to respond, with the North American Industry Classification System code 325998 indicating it falls under other miscellaneous chemical product and preparation manufacturing. The solicitation was posted on July 6, 2026, with a firm deadline for responses on July 16, 2026, at 3:30 PM ET, and is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The place of performance and point of contact details are not specified, but the work is expected to be performed in alignment with federal procurement guidelines and quality standards applicable to biomedical research instruments.